ProMIS Neurosciences (PMN) Earnings Analysis
ProMIS Neurosciences (PMN) next reports earnings on 2026-08-12, consensus EPS -1.45 USD. Last quarter (2026-05-11) it missed with EPS -1.26 USD vs -1.06 USD est (-18.9%). It has beaten estimates in 3/8 recent quarters (38%). Trailing P/E -0.59.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does PMN next report earnings?
| Next earnings date | 2026-08-12 |
|---|---|
| Consensus EPS estimate | -1.45 USD |
| Revenue estimate | n/a |
PMN earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-11 | -1.26 USD | -1.06 USD | -18.9% | Miss |
| 2026-03-25 | -4.11 USD | -4.66 USD | +11.8% | Beat |
| 2025-11-12 | -6 USD | -3.75 USD | -60% | Miss |
| 2025-08-13 | -0.29 USD | -0.22 USD | -31.8% | Miss |
| 2025-05-12 | -0.21 USD | -0.12 USD | -75% | Miss |
| 2025-03-31 | -0.02 USD | -0.14 USD | +85.7% | Beat |
| 2024-11-14 | -0.14 USD | -0.07 USD | -100% | Miss |
| 2024-08-08 | -0.13 USD | -0.14 USD | +7.1% | Beat |
Beat rate: 3/8 (38%) over reported quarters with consensus data.
PMN valuation and analyst view
| Trailing P/E | -0.59 |
|---|---|
| Trailing EPS | -6.22197 USD |
| Price / book | 1.50 |
| Dividend yield | 0.00% |
| Market cap | 0.02B |
| Analyst consensus | Buy (2 buy / 0 hold / 0 sell) |
| Avg price target | 19 USD |
Related research pages
Frequently asked questions
When is ProMIS Neurosciences (PMN)'s next earnings date?
ProMIS Neurosciences is next scheduled to report on 2026-08-12, with a consensus EPS estimate of -1.45 USD.
Did PMN beat earnings last quarter?
In its 2026-05-11 report, PMN posted EPS of -1.26 USD versus a -1.06 USD estimate — a miss of 18.9%.
What is PMN's earnings track record?
Over the last 8 reported quarters with consensus data, PMN beat estimates 3 times (38%).
What is PMN's current P/E ratio and EPS?
PMN trades at a trailing P/E of -0.59 on trailing EPS of -6.2219653882277575 USD.
What do analysts rate PMN?
Analyst consensus is "Buy" across 2 ratings (0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell). Average 12-month price target: 19 USD.